Data from the co-IP assay indicated that CHIP overexpression suppressed hyperglycemia-induced p53 expression (Fig. 4A), directly interacted with phosphorylated p53 for ubiquitination, allowing for ubiquitination-mediated proteasomal degradation (Fig. 4B-C). Here, TP53 is linked to Hyperglycemia.